18-26227080-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_005640.3(TAF4B):āc.147T>Cā(p.Pro49=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00126 in 1,606,964 control chromosomes in the GnomAD database, including 24 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0066 ( 12 hom., cov: 32)
Exomes š: 0.00070 ( 12 hom. )
Consequence
TAF4B
NM_005640.3 synonymous
NM_005640.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.322
Genes affected
TAF4B (HGNC:11538): (TATA-box binding protein associated factor 4b) TATA binding protein (TBP) and TBP-associated factors (TAFs) participate in the formation of the TFIID protein complex, which is involved in initiation of transcription of genes by RNA polymerase II. This gene encodes a cell type-specific TAF that may be responsible for mediating transcription by a subset of activators in B cells. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jun 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BP6
Variant 18-26227080-T-C is Benign according to our data. Variant chr18-26227080-T-C is described in ClinVar as [Benign]. Clinvar id is 786339.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.322 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00663 (1010/152230) while in subpopulation AFR AF= 0.0233 (970/41546). AF 95% confidence interval is 0.0221. There are 12 homozygotes in gnomad4. There are 446 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 12 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAF4B | NM_005640.3 | c.147T>C | p.Pro49= | synonymous_variant | 1/15 | ENST00000269142.10 | NP_005631.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAF4B | ENST00000269142.10 | c.147T>C | p.Pro49= | synonymous_variant | 1/15 | 1 | NM_005640.3 | ENSP00000269142 | P4 | |
TAF4B | ENST00000578121.5 | c.147T>C | p.Pro49= | synonymous_variant | 1/15 | 2 | ENSP00000462980 | A2 | ||
TAF4B | ENST00000418698.3 | c.147T>C | p.Pro49= | synonymous_variant, NMD_transcript_variant | 1/16 | 5 | ENSP00000389365 |
Frequencies
GnomAD3 genomes AF: 0.00661 AC: 1006AN: 152114Hom.: 12 Cov.: 32
GnomAD3 genomes
AF:
AC:
1006
AN:
152114
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00162 AC: 378AN: 233428Hom.: 4 AF XY: 0.00113 AC XY: 145AN XY: 128206
GnomAD3 exomes
AF:
AC:
378
AN:
233428
Hom.:
AF XY:
AC XY:
145
AN XY:
128206
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000702 AC: 1021AN: 1454734Hom.: 12 Cov.: 31 AF XY: 0.000620 AC XY: 449AN XY: 723922
GnomAD4 exome
AF:
AC:
1021
AN:
1454734
Hom.:
Cov.:
31
AF XY:
AC XY:
449
AN XY:
723922
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00663 AC: 1010AN: 152230Hom.: 12 Cov.: 32 AF XY: 0.00599 AC XY: 446AN XY: 74432
GnomAD4 genome
AF:
AC:
1010
AN:
152230
Hom.:
Cov.:
32
AF XY:
AC XY:
446
AN XY:
74432
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
10
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
TAF4B-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 16, 2024 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at